Nanopublication

< Home

ID

http://purl.org/np/RAe9r2sGtT2KUf1OLl7Oj41jzfL8468A4XFnT_7cYwdnw

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAe9r2sGtT2KUf1OLl7Oj41jzfL8468A4XFnT_7cYwdnw> .
@prefix sub: <http://purl.org/np/RAe9r2sGtT2KUf1OLl7Oj41jzfL8468A4XFnT_7cYwdnw#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns1:C0026538 "morbidity";
    ns1:C0220880 "morbidity" .
  
  rdf:predicate ns3:TRIPLE_UID:e583sv4c-TRIPLE-ABSTRACT-4 "reduce" .
  
  rdf:subject ns1:C0011777 "dexamethasone";
    ns1:C0035222 "ARDS";
    ns1:C0348016 "intravenous";
    ns1:C0443211 "established";
    ns1:C1272684 "established";
    ns1:C3858690 "adjunctive treatment";
    ns1:C5203670 "coronavirus disease 2019" .
  
  rdfs:Triple-UID ns2:TRIPLE_UID:e583sv4c-TRIPLE-ABSTRACT-4 "e583sv4c-TRIPLE-ABSTRACT-4" .
  
  rdfs:sentence rdfs:label "We postulated that adjunctive treatment of established ARDS caused by the coronavirus disease 2019 (COVID)-19) with intravenous dexamethasone might change the pulmonary and systemic inflammatory response and thereby reduce morbidity, leading to a decrease in duration of mechanical ventilation and in mortality." .
  
  rdfs:triple rdfs:label "adjunctive treatment of established ARDS caused by the coronavirus disease 2019 ( COVID)-19 ) with intravenous dexamethasone reduce morbidity" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:46:48.148404"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "DEpg0U+ilcSNcfqDkkUxXshfdLl8xWduLxVgOCgNI4DJ0JQIL+WzMklblGd3COLIxILfyprai4+PfCoN2CPymhhzs5YVk6Wx4bnHaf1csvUOcP/o7pGuH3KDnt8qZQ5gI1UWBsSlfmyp87J81pykDHo5M/vtrBtty6/vCmGUsJw=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:46:48.148404"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}